Group Leader, Antibody–Oligo Conjugates (AOC)

You are an experienced bioconjugation or AOC‑focused scientist who thrives in discovery. You know how to design, implement, and optimise antibody–oligo conjugates, build assays, validate constructs, and move programmes toward candidate selection. You want to lead a function, build a team, and shape an emerging therapeutic platform from the ground up.

A newly established RNA‑therapeutics initiative is scaling rapidly and now seeks a Group Leader, Antibody–Oligo Conjugates to lead AOC engineering, bioconjugation workflows, assay development, and cross‑functional integration. The programme is expanding from 13 to ~80 scientists and needs leaders who “make things happen,” build systems, and deliver progress at pace.

THE ROLE

You will lead the AOC engineering and bioconjugation strategy, implementing antibody‑based tissue‑targeting approaches while simultaneously building the team around you. You...